Immunotherapy Helps Extend the Lives of Patients with Rare Form of Skin Cancer

Immunotherapy helps extend the lives of patients with rare form of skin cancer

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can effectively shrink or eliminate tumors in patients with unresectable advanced desmoplastic melanoma, a rare and often aggressive form of skin cancer.

Immunotherapy Helps Extend the Lives of Patients with Rare Form of Skin Cancer

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can effectively shrink or eliminate tumors in patients with unresectable advanced desmoplastic melanoma, a rare and often aggressive form of skin cancer.